Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: a retrospective cohort study

Fig. 3

Kaplan-Meier survival curves of in-hospital death among patients in whom treatment with ARBs was continued as compared to those in whom ACEIs was continued (defined in the first 3-day window). Abbreviations: ACEIs angiotensin-converting enzyme inhibitors, ARBs angiotensin receptor blockers. *Log-rank test

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us